Phase I Clinical Study of Intralesional TLR-7-Agonist (LHC165) with PD-1 Inhibitor Spartalizumab in Patients with Advanced PD1-resistant Solid Tumors
95th Annual Meeting German Society of Oto-Rhino-Laryngology, Head and Neck Surgery e V, Bonn Laryngo-Rhino-Otologie（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined